Resultados de la búsqueda 601-610 of 20438 for Two-phase
Randomized Phase II/III Trial of Adjuvant ... A Study to Compare Two Surgical Procedures in Women With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer.
The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...
The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...
... 2 (cohort expansion in two cohorts). Phase 1/2 Study Of MRTX1719 In Solid Tumors With MTAP Deletion. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix ...
The purpose of part two of this study is to evaluate safety and ... In Part 2 Cohort 2, a safety run in and expansion phase will be undertaken ...
Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...
... Phase 2 dose (RP2D) for \[177Lu\]Lu FAP 2286 monotherapy in participants with FAP expressing solid tumors. Phase 2 is designed to evaluate the safety and ...
... Phase 1/2 study in a selected cohort of patient with LM. Prehabilitation. Rochester, Minn. Physical activity plays an important role in reducing the adverse ...
Phase 1/2 Study Of MRTX1719 In Solid Tumors With MTAP Deletion. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?